These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17163821)

  • 21. Combining the audit questionnaire and biochemical markers to assess alcohol use and risk of alcohol withdrawal in medical inpatients.
    Dolman JM; Hawkes ND
    Alcohol Alcohol; 2005; 40(6):515-9. PubMed ID: 16103035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activity of beta-hexosaminidase (uHex) and gamma-glutamyl-transferase (uGGT) in urine as non-invasive markers of chronic alcohol abuse: I. Alcohol-dependent subjects.
    Taracha E; Habrat B; Woźniak P; Walkowiak J; Szukalski B
    World J Biol Psychiatry; 2001 Oct; 2(4):184-9. PubMed ID: 12587147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Utility of investigations by family physician of some biological parameters in chronic alcoholism].
    Pavel L; Manole A
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):885-8. PubMed ID: 18389774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between biological state markers of alcohol abuse and severity of alcohol dependence syndrome.
    Monteiro MG; Masur J
    Alcohol; 1987; 4(2):135-7. PubMed ID: 2883983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-Glutamyl Transferase: A Useful Marker of Habitual Drinking in Cases of Alcohol-Associated Osteonecrosis of the Femoral Head.
    Hamada H; Ando W; Takao M; Sugano N
    Alcohol Alcohol; 2021 Feb; 56(2):175-180. PubMed ID: 33179047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease.
    Franzini M; Fornaciari I; Fierabracci V; Elawadi HA; Bolognesi V; Maltinti S; Ricchiuti A; De Bortoli N; Marchi S; Pompella A; Passino C; Emdin M; Paolicchi A
    Liver Int; 2012 Apr; 32(4):629-34. PubMed ID: 22098947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
    Conigrave KM; Degenhardt LJ; Whitfield JB; Saunders JB; Helander A; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Mar; 26(3):332-9. PubMed ID: 11923585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of alcohol abuse and monitoring of alcoholic abstinence using sideroblastic index and gamma-glutamyltransferase].
    Boewer C; Roschlau G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):777-99. PubMed ID: 2416655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enzyme diagnostic criteria of alcoholism].
    Piatnitskaia IN; Chernobrovkina TV; Goriushkin II
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(7):1051-3. PubMed ID: 2863908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic tests for alcohol consumption.
    Conigrave KM; Saunders JB; Whitfield JB
    Alcohol Alcohol; 1995 Jan; 30(1):13-26. PubMed ID: 7748270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program.
    Irwin M; Baird S; Smith TL; Schuckit M
    Am J Psychiatry; 1988 May; 145(5):595-9. PubMed ID: 2895984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum beta-hexosaminidase isoenzyme: a sensitive marker for alcohol abuse.
    Hultberg B; Isaksson A; Berglund M; Moberg AL
    Alcohol Clin Exp Res; 1991 Jun; 15(3):549-52. PubMed ID: 1831603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among US adults.
    Tsai J; Ford ES; Li C; Zhao G
    Addict Behav; 2012 Jan; 37(1):78-84. PubMed ID: 21975024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of indirect alcohol biomarkers for predicting recidivism of drunk-driving among previously convicted drunk-driving offenders: results from the recidivism of alcohol-impaired driving (ROAD) study.
    Maenhout TM; Poll A; Vermassen T; De Buyzere ML; Delanghe JR;
    Addiction; 2014 Jan; 109(1):71-8. PubMed ID: 24438112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Bayesian Alcoholism Test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use.
    Korzec A; de Bruijn C; van Lambalgen M
    J Clin Epidemiol; 2005 Oct; 58(10):1024-32. PubMed ID: 16168348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of laboratory markers and the audit questionnaire by primary care physicians to detect alcohol abuse by patients.
    Aalto M; Seppä K
    Alcohol Alcohol; 2005; 40(6):520-3. PubMed ID: 16215269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory markers as compared to drinking measures before and after inpatient treatment for alcoholism.
    Keso L; Salaspuro M
    Alcohol Clin Exp Res; 1989 Jun; 13(3):449-52. PubMed ID: 2568766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers.
    Alatalo P; Koivisto H; Puukka K; Hietala J; Anttila P; Bloigu R; Niemelä O
    Alcohol Alcohol; 2009; 44(2):199-203. PubMed ID: 19054785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of moderate drinking and abstinence on serum and urinary beta-hexosaminidase levels.
    Kärkkäinen P; Jokelainen K; Roine R; Suokas A; Salaspuro M
    Drug Alcohol Depend; 1990 Feb; 25(1):35-8. PubMed ID: 1969791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.